A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome

NCT05211830 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Netherton Syndrome

Interventions

DRUG: SXR1096 cream
DRUG: Placebo cream

Sponsor

Sixera Pharma